ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1773

Otolaryngologic Lesions Are Not Rare and Closely Related with Pachymeningitis and Cranial Neuropathy in MPO-ANCA Associated Vasculitis

Takahiro Nunokawa1, Naoto Yokogawa2, Kota Shimada1 and Shoji Sugii2, 1Department of Rheumatic diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan, 2Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: ANCA, myeloperoxidase (MPO) and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Recently several case reports of serous otitis media (SOM), hypertrophic pachymeningitis (HP) and cranial neuropathy (CN) have been reported in connection with MPO-ANCA associated vasculitis (MPO-AAV). However, there are few clinical studies on the lesions. Herein, we address the frequency and the characteristics of these manifestations in patients with MPO-AAV

Methods:

This retrospective study focused on consecutive patients in whom MPO-AAV was diagnosed between 2003 and 2014 at Tokyo Metropolitan Tama Medical Center. We investigated their clinical and radiological profile by reviewing the medical records.

Results:

A total of 111 patients with MPO-AAV were seen at the hospital in this period. There were 19 patients (17%) with at least one of the manifestations: SOM, HP, or CN. SOM was observed in 16 cases (14%), and constituted the first manifestation of the disease in 11 cases. HP and CN were seen in eight (7%) and seven (6%) patients, respectively. Of the patients presenting with SOM, seven patients had HP and/or CN (4 with HP and CN, 2 with CN, 1 with HP). Of three HP patients unassociated with SOM, CN was detected in one. There were no patients with isolated CN. Of the 11 patients examined by MRI, six patients demonstrated intense inflammation in the epipharynx. There was a significant difference in the rate of glomerulonephritis between the patients with the manifestations and those without them (32% vs. 73%; P = 0.0006). Furthermore, none of the patients with HP exhibited glomerulonephritis.

Conclusion:

SOM is not a rare manifestation in MPO-AAV and often precedes other manifestations. There is a close relationship among SOM, HP and CN. Inflammation in the epipharynx might play a role as a pre-condition for the development of SOM and HP.


Disclosure:

T. Nunokawa,
None;

N. Yokogawa,
None;

K. Shimada,
None;

S. Sugii,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/otolaryngologic-lesions-are-not-rare-and-closely-related-with-pachymeningitis-and-cranial-neuropathy-in-mpo-anca-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology